BioSpace News Archive

ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will participate in a virtual fireside chat at the Morgan Stanley 18 th Annual Global Healthcare Conference on Monday, September 14, 2020, beginning at approximately 12:45 p.m. (Eastern Daylight Time) via video webcast.

- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced its participation at two upcoming virtual investor conferences. Michael S. Weiss, the Company’s Executive Chairman and Chief Executive Officer, is scheduled to participate in fireside chats during the following conferences: The H.C. Wainwright 22nd Annual Global Investment Conference – fireside chat scheduled to take place on Monday, September 14, 2020 at 1:30 PM ET The Cantor Fitzgerald Globa

Fountain Therapeutics (“Fountain”), a biopharmaceutical company building a pipeline of therapeutics to treat age-related diseases by reversing cellular age, today announced it has moved its corporate headquarters to Lilly Gateway Labs in South San Francisco upon selection by Eli Lilly and Company.

Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) today announced that an independent analyst report by Ari Zoldan was published on Seeking Alpha, a crowd-sourced content service for financial markets.

Misonix, Inc. (Nasdaq: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today announced that it will be participating in the Cantor Virtual Global Healthcare Conference.

Happiness Biotech Group Limited, an innovative China-based nutraceutical and dietary supplements producer, announced that the Company has set up a wholly owned subsidiary “Happy Buy Internet Technology Co., Ltd.” focusing on further developing the Company’s e-Commerce business.

Allegheny Health Network (AHN) today announced the appointment of Margaret Larkins-Pettigrew, MD, MEd, MPPM, FACOG, as the health system’s first Chief Clinical Diversity & Inclusion Officer (CCDIO).

Life science innovator Paragon Biosciences announced the appointment of Jon T. DeVries as the new chief executive officer of its portfolio company, Qlarity Imaging, a leading artificial intelligence (AI) diagnostics company

Leia Inc. and Infuse Medical have joined forces to revolutionize medical training and education with immersive 3D and 2D educational experiences.

Syneos Health®, the only fully integrated biopharmaceutical solutions organization combining a CRO and a CCO, announced that the Company’s presentation at the Baird 2020 Global Healthcare Conference has been rescheduled because of technical issues.